Further, cGAS/STING is implicated in the pathology of CNS neurodegenerative diseases, such as AD/ADRD (24–26), Parkinson’s disease (27), and amyotrophic lateral sclerosis (28), and may thus constitute a “bridge” between metabolic dysfunction and cognitive impairment. This evidence concerns the gene CGAS and Parkinson disease.